Figure 6

IFNT promotes proangiogenic factors in LGCs. LGCs were treated with either basal media (control) or roIFNT (1 and 10 ng/mL). (a,b) FGF2 mRNA and protein levels. (c) PDGFB and (d) PDGFAR mRNA expression. Asterisks indicate significant differences between roIFNT treatment and controls (*P < 0.05, **P < 0.01, ***P < 0.001).